User Name Password

back to homepage

Selwyn Resources (SWN.V) - releases further encouraging assays

Comment by Objective Capital , Nov 07, 2007
Questions? Contact our analyst

Selwyn Resources continues to produce encouraging assays from its Selwyn deposit in Yukon, Canada. The latest intersections, released today, show combined lead and zinc values of between 5.5 percent and 6.15 per cent over true widths ranging from ten to twenty metres. These results come from the south-eastern margin of the Don deposit, where no previous drilling occurred and thus represent an expansion of the mineral potential of the area.

Late in October, the company produced assays averaging between 6.7 percent and 9.0 percent of combined lead and zinc, over comparable widths in the HC West deposit, while a hole at Don East produced 14.37 percent lead and zinc over a 15.76-metre width.

Objective's view:

We continue to view the higher-grade lead and zinc intersections as a positive development for Selwyn Resources. Drilling will continue using four rigs to prove the continuity of the higher-grade material and the company expects to have an updated resource calculation by the end of January. Work will continue thereafter, which could allow the company to upgrade the resource from an inferred category.

We expect that the company will actively re-examine its mining options at Selwyn. The existing plan commences with an open pit at the XY deposit, but the high-grade zones allow the company the option of moving forward plans for underground mining. If such a decision were taken it could lead to an increase in operating costs, but lower capital costs. Combined with the higher grades, the net effect could be a faster payback.

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer